Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.
| Year | ID | Type | Category | Title | Authors |
|---|
| 2018 | FC03 | Poster | Family and Caregivers |
Complex Changes MS Healthcare: Indirect Care |
Malory Weber, MBA1, Pete Swauger, RN1, Kim Lansu, Med Sec1, Janet Perryman, MBA1, Tanya Ray, Med Sec1, Mary Roe, Med Sec1, Robin Treece, Med Sec1, Lauren Wyeth, MS2 and Robert Bermel, MD3, (1)Mellen Center, Cleveland Clinic, Cleveland, OH, (2)Continuous Improvement, Cleveland Clinic, Cleveland, OH, (3)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH |
| 2018 | FC04 | Poster | Family and Caregivers |
Pregnancy and Multiple Sclerosis Disease Activity in Women from the New York State Multiple Sclerosis Consortium |
Caila B Vaughn, PhD, MPH1,2, Katelyn S. Kavak, MS1,2, Karen Zakalik, MBA1,2, Barbara E. Teter, PhD, MPH1,2, Muhammad Nadeem, MD1, Andrew Goodman, MD2,3, Keith R Edwards, MD2,4, Rozina Rana, MD2,5, Malcolm Gottesman, MD2,5 and Bianca Weinstock-Guttman, MD1,2, (1)Jacobs MS Center for Treatment and Research, Buffalo, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY, (3)Neurology, University of Rochester, Rochester, NY, (4)MS Center of Northeastern New York, Latham, NY, (5)Comprehensive MS Care Center, NYU Winthrop Hospital, Mineola, NY |
| 2018 | IM01 | Poster | Imaging |
Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism |
Allison Fryman, MPH1, Michael Lane, MD1,2, Manoj Sammi, PhD3, Frank Bittner, DO1,2, Dennis Bourdette, MD1,2, William Rooney, PhD3 and Vijayshree Yadav, MD1,2, (1)VA Portland Health Care System, Portland, OR, (2)Neurology, Oregon Health & Science University, Portland, OR, (3)Advanced Imaging Research Center, Oregon Health Science University, Portland, OR |
| 2018 | IM02 | Poster | Imaging |
Relationship between MRI Reported Lesion Location with Gait Speed and Disability Status in Multiple Sclerosis |
Lyndsay A Hauser, BA1, Lisa H Conti, PhD1, Richard Feinn, PhD1, Carolyn J. St. Andre, BS2, Lindsay Neto, MPH2 and Jennifer A. Ruiz, DPT2, (1)Department of Medical Sciences, Frank H Netter MD School of Medicine, Quinnipiac University, North Haven, CT, (2)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT |
| 2018 | IM03 | Poster | Imaging |
A Rare Imaging Finding in Multiple Sclerosis : Wallerian Degeneration of the Corticospinal Tract |
Nidhiben Anadani, MBBS, Megan Hyland, MD, Andrew Goodman, MD and Lawrence Samkoff, MD, Neurology, University of Rochester, Rochester, NY |
| 2018 | IM04 | Poster | Imaging |
Comparative Longitudinal Analysis of Fingolimod Versus Glatitamer Acetate in Myelin Repair and Tissue Integrity: A 24-Months Follow-up Study. |
Sara Razmjou, MD, M.Sc1, Fen Bao, MS2, Samuel Lichtman-Mikol, BA1, Kalyan Yarraguntla, MD2, Carla Santiago, MS2, Evanthia Bernitsas, MD3 and Navid Seraji-Bozorgzad, MD, M.Sc1, (1)Neurology, Wayne State School of Medicine, Detroit, MI, (2)Wayne State School of Medicine, Detroit, MI, (3)Neurology, Wayne State University School of Medicine, Detroit, MI |
| 2018 | IS01 | Poster | Internet and Information Services |
Multiple Sclerosis (MS) Database Integrated with the Electronic Health Record (EHR) Promotes Dissemination of Clinical Picture across Teams and Saves Time |
Kimberly L Cooley, RN, CCRC, Research, OSF Saint Francis Medical Center, Peoria, IL |
| 2018 | IS02 | Poster | Internet and Information Services |
A Mapping Study Comparing Educational Resources for Multiple Sclerosis Patients across the USA, Latin America, Middle East and Asia-Pacific Regions |
Professor Dawn Langdon, MA, MPhil, PhD, AFBPS, Department of Psychology Clinical, Health and Social Psychology, Royal Holloway, University of London, Egham, United Kingdom, Peter Rieckmann, MD, Loipl Specialist Clinic for Neurology, Medical Park, Loipl Specialist Clinic for Neurology, Loipl, Germany, Elisabetta Verdun di Cantogno, MD, PhD, Merck KGaA, Darmstadt, Germany and Sarah A Morrow, MD, FRCPC, MS, Clinical Neurological Sciences, London Health Sciences Centre, London, ON, Canada |
| 2018 | IS03 | Poster | Internet and Information Services |
A Predictive Model of Initial Hospitalization Cost in Patients with Multiple Sclerosis |
Kanika Sharma, MD1, John A Kamholz, MD, PhD1, Frank R Bittner, MD1 and Piyush Kalakoti, MD2, (1)Neurology, University of Iowa, Iowa City, IA, (2)University of Iowa, Iowa City, IA |
| 2018 | MC01 | Poster | Methods of Care |
Seroconversion of Serum NMO IgG in Initial Seronegative NMO IgG and Positive CSF NMO IgG Antibody Neuromyelitis Optica Case |
Deepmala Nandanwar, MD, Wayne State University / Detroit Medical Center, Detroit, MI and Evanthia Bernitsas, MD, Neurology, Wayne State University School of Medicine, Detroit, MI |
| 2018 | MC02 | Poster | Methods of Care |
Factors Influencing Best Practices in Treating Multiple Sclerosis: Results from a Predictive Modeling Analysis |
Jamie Reiter, PhD, Jan Perez, BS, Sharon Tordoff, BS and Whitney Faler, MPA, CME Outfitters, LLC, Bethesda, MD |
| 2018 | MC03 | Poster | Methods of Care |
Association of 30-Day Continuity of Care with Outcomes in Multiple Sclerosis |
Kanika Sharma, MD1, Yubo Gao, PhD2, Junlin Liao, PhD3, John A Kamholz, MD, PhD1 and Frank R Bittner, MD1, (1)Neurology, University of Iowa, Iowa City, IA, (2)Medicine, University of Iowa, Iowa City, IA, (3)Surgery, University of Iowa, Iowa City, IA |
| 2018 | MC04 | Poster | Methods of Care |
Implementing a Brain Health-Focused Approach to Multiple Sclerosis Care: Global and Local MS Brain Health Initiatives |
Jodi Haartsen, Master of Nursing, Post Graduate Diploma of Neuroscience Nursing, Graduate Diploma of Applied Science, Eastern Health, Victoria, Australia, Jeremy Hobart, BSc PhD FRCP Dip Public Health, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom, Amy Bowen, CBiol MRSB (Chartered Biologist, Member of the Royal Society of Biology), NHS RightCare, London, United Kingdom, Lucy Eberhard, PhD, PharmaGenesis London, London, United Kingdom, George Pepper, -, Shift.ms, Leeds, United Kingdom and Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath, Queen Mary University London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom |
| 2018 | MC05 | Poster | Methods of Care |
Can We Move the Wellness “Needle” with Shared Medical Appointments for MS Patients? |
Mary R Rensel, MD, FAAN, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH and S. Bassi, BS, CWRU, Cleveland, OH |
| 2018 | MC06 | Poster | Methods of Care |
An MS Academic Center Experience with Ocrelizumab and Implications for Increasing Staffing Needs |
Brooke McCartney, BSN, RN, Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, TX, Paula Hardeman, PA-C, Neurology & Neurotherapeutics – MS Clinic, UT Southwestern Medical Center, Dallas, TX and Benjamin Greenberg, MD, MHS, Department of Neurology, UT Southwestern, Dallas, TX |
| 2018 | MC07 | Poster | Methods of Care |
Burnaby Electronic Tool for Safety Monitoring of Patients on MS Disease Modifying Therapies (BESAFE DMT) |
Jill R Nelson, RN BScN MSCN, Anna Kazimirchik, RN MSCN, Tatstsyana Kadach, MEng and Galina Vorobeychik, MD, FRCPS(C), CMSC, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada |
| 2018 | MC08 | Poster | Methods of Care |
The Clinical Research Navigator: A Novel Role and Its Impact on Research Participation By Clinic Patients. |
Danielle M Taylor, BA1, Refujia Gomez, BS1, Amber Alexander, MSc2, Jennifer Arjona, BA, MS2, Sergio Baranzini, PhD1,3,4, Patrick Barba, BS5, Bruce AC Cree, MD, PhD1, Michael Devereux, B.S.2, Samuel Friedman, BS2, Priya Garcha, BSc2, Jeffrey M Gelfand, MD, MAS1, Douglas S. Goodin, MD1, Jennifer S Graves, M.D. PhD1, Ari J Green, MD1, Ariele Greenfield, MD1, Stephen L Hauser, MD1, Roland Henry, PhD1, Xiaoming Jia, MD1, Liana Kanaaneh, BA2, Kristen Krysko, MD1, Robin Lincoln, BS1, Michael Manguinao, BS2, Naomi Okinishi, MPH2, Jorge Oksenberg, PhD1, Samuel Pleasure, MD, PhD1, Nicholas Ragan, BSc5, Nisha Revirajan, MD2, Andrew Romeo, MD1, Gillian Rush, BSc5, Joseph Sabatino Jr., MD, PhD1, Ryan Schubert, MD1, Nancy Shum, BS2, Sneha Singh, BSc2, Collin Spencer, BS2, Emmanuelle Waubant, MD, PhD1, Michael Wilson, MD1, Scott Zamvil, MD, PhD1 and Riley Bove, MD, MMSc1, (1)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA, (2)UCSF Neurology, MS Research Coordinators, San Francisco, CA, (3)Institute for Human Genetics, University of California, San Francisco, CA, (4)Graduate Program in Bioinformatics, University of California, San Francisco, San Francisco, CA, (5)UCSF Neurology, MS EPIC Team, San Francisco, CA |
| 2018 | MC09 | Poster | Methods of Care |
Clinic to in-Home Telemedicine Reduces Barriers to Care for Patients with Multiple Sclerosis and Neuroinflammation |
Priya Garcha, BSc1, Carolyn J Bevan, MD2, Elizabeth Crabtree-Hartman, MD, MAS2, Ari J Green, MD1, Jeffrey M Gelfand, MD, MAS1 and Riley Bove, MD, MMSc3, (1)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA, (2)UCSF Neurology, Weill Institute for the Neurosciences, San Francisco, CA, (3)University of California San Francisco, Weill Institute for Neurosciences, San Francisco, CA |
| 2018 | MC10 | Poster | Methods of Care |
Validating Unsupervised Digital Cognitive Evaluations and Training Tools in Multiple Sclerosis |
Priya Garcha, BSc1, Gillian Rush, BSc1, John Morrissey, BSc1, Chao Zhao, MSc1, Katherine Possin, PhD1, Anthony Feinstein, PhD, MD2, Joaquin Anguera, PhD1 and Riley Bove, MD, MMSc3, (1)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA, (2)Psychiatry, University of Toronto, Toronto, ON, Canada, (3)University of California San Francisco, Weill Institute for Neurosciences, San Francisco, CA |
| 2018 | MC11 | Poster | Methods of Care |
A Retrospective, Single Institution Study of Tumefactive Multiple Sclerosis |
Anastasie Dunn-Pirio, MD, MS, Suma Shah, MD and Christopher Eckstein, MD, Neurology, Duke University, Durham, NC |
| 2018 | MD01 | Poster | Multidisciplinary Care |
Effect of Chronic Medical Conditions in Veterans with Multiple Sclerosis on Long-Term Disability |
Meheroz H Rabadi, MD, MRCPI, FAAN, FANA, Neurology, OKC VA Med Ctenter, Oklahoma City, OK |
| 2018 | MD02 | Poster | Multidisciplinary Care |
Predictors of Mortality in Veterans with Multiple Sclerosis in an out-Patient Clinic Setting |
Meheroz H Rabadi, MD, MRCPI, FAAN, FANA, Neurology, OKC VA Med Ctr, Oklahoma City, OK and Christopher E Aston, Ph.D, Pedeatrics, OU Medical Center, Oklahoma City, OK |
| 2018 | MD03 | Poster | Multidisciplinary Care |
MS Centers: Their Voyage to the New World of Health Care |
John P Conomy, MD JD, Health Systems Design, Inc, Chagrin Falls, OH |
| 2018 | MD04 | Poster | Multidisciplinary Care |
HCPs and the Management of MS: Online Medical Education Improves Knowledge of Nurses and Nurse Practitioners |
Thomas Finnegan, PhD, Medscape LLC, New York, NY, Colleen Harris, MN, NP, MSCN, MSCS, University of Calgary MS Clinic, Hackensack, NJ and Aliza Ben-Zacharia, DNP, ANP, MSCN, Neurology, Mount Sinai Hospital, New York, NY |
| 2018 | MD05 | Poster | Multidisciplinary Care |
Independent Study Highlights Differences between Advanced Practice Providers and Neurologists in Monoclonal Antibody Disease-Modifying Therapies Use |
Virginia R Schobel, MSc, Neurology Market Intelligence, Spherix Global Insights, Exton, PA and Jennifer Robinson, BS, President, Spherix Global Insights, Exton, PA |
| 2018 | MD06 | Poster | Multidisciplinary Care |
Diagnosis of Infertility and Infertility Treatment in Women with and without Multiple Sclerosis |
Maria K Houtchens, MD1, Natalie C Edwards, MSc2, Brooke Hayward, SM, MBA3 and Amy L Phillips, PharmD3, (1)Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, (2)Health Services Consulting Corporation, Boxborough, MA, (3)EMD Serono, Inc., Rockland, MA |
| 2018 | MD07 | Poster | Multidisciplinary Care |
Quality Improvement: Optimizing Antibiotic Use and Bacteriuria Screening in Patients with Multiple Sclerosis and Other Central Demyelinating Diseases |
Tyler E Smith, MD1, Katherine Baumgarten, MD2, Jonathan Hand, MD2, Amber E Peskin, AGCNS-BC, MSCN3 and Bridget A Bagert, MD1, (1)Neurology, Ochsner Clinic Foundation, New Orleans, LA, (2)Infectious Diseases, Ochsner Clinic Foundation, New Orleans, LA, (3)Ochsner Multiple Sclerosis Center, New Orleans, LA |
| 2018 | MD08 | Poster | Multidisciplinary Care |
A Novel Multidisciplinary Approach to Fatigue in Multiple Sclerosis |
Alison Kraus, PT, DPT, NCS1,2, Nicole Tester, PhD, MOT, OTR/L1, Tirisham V Gyang, MD2, Lindsay Falk, ARNP, MSCN2, Vineet Nadkarni, BS2 and Augusto Miravalle, MD2, (1)Rehabilitation, UF Health, Gainesville, FL, (2)Neurology, University of Florida, Gainesville, FL |
| 2018 | MD09 | Poster | Multidisciplinary Care |
Timed 25 Foot Walk Times Are Predictive of EDSS in Persons with MS |
Warren Berger, MD, FRCPC1, Sarah A Morrow, MD, FRCPC, MS1 and Michael WC Payne, MSc, MD, FRCPC2, (1)Clinical Neurological Sciences, London Health Sciences Centre, London, ON, Canada, (2)Department of Physical Medicine and Rehabilitation, St. Joseph’s Health Care, London, ON, Canada |
| 2018 | MD10 | Poster | Multidisciplinary Care |
Time Spent with Adequate Supply of Dimethyl Fumarate in a Specialty Pharmacist-Led Monitoring Program Versus Standard Dispensation in British Columbia |
Jamie Head, BSc1, Ana-Luiza Sayao, MD2, Carolyn Taylor, MSc3, Lorne Kastrukoff, MD2, Anthony Traboulsee, MD2,4, Virginia Devonshire, MD2 and Robert Carruthers, MD2, (1)Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada, (2)Neurology, University of British Columbia, Vancouver, BC, Canada, (3)Department of Statistics, University of British Columbia, Vancouver, BC, Canada, (4)University of British Columbia, Vancouver, BC, Canada |
| 2018 | NB01 | Poster | Non-imaging Biomarkers |
Phosphorylated SIRT1 As a Biomarker of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis |
Jonathan Ciriello, B.S.1, Alexandru Tatomir, M.D.1, Daniel Hewes, B.S.1, Vinh Nguyen, D.D.S.2, Walter Royal III, M.D.3, Violeta Rus, M.D., Ph.D.2 and Horea Rus, M.D., Ph.D.3, (1)Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, (2)Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, (3)Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD |
| 2018 | NB02 | Poster | Non-imaging Biomarkers |
Eyetracking in Pediatric Patients with Multiple Sclerosis |
Andrew Yousef, B.S.1, Michael Devereux, B.S.2, Pierre-Antoine Gourrard, PhD1, Soren Jonzzon, MA1, Leena Suleiman, BA3, Emmanuelle Waubant, MD, PhD4,5, Ari Green, MD1 and Jennifer Graves, MD, PhD, MAS1,4, (1)Neurology, UC San Francisco, San Francisco, CA, (2)Neurology, University of California, San Francisco, CA, (3)Neurology, UCSF, San Francisco, CA, (4)UCSF Pediatric MS Center, San Francisco, CA, (5)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA |
| 2018 | NB03 | Poster | Non-imaging Biomarkers |
Oligoclonal Band Number Correlates with Relapses and Progression in Multiple Sclerosis |
Christopher Perrone, MD, Joseph Berger, MD and Clyde Markowitz, MD, Neurology, University of Pennsylvania, Philadelphia, PA |
| 2018 | NB04 | Poster | Non-imaging Biomarkers |
Comparison of an iPAD-Based Visual Assessment and Sloan Letter Acuity Testing in Multiple Sclerosis Patients |
Thomas J Shoemaker, MD1, Peter A Calabresi, MD2, Shiv Saidha, MBBCh2, Natalia Gonzalez-Caldito, MD3, Sydney Feldman, BS2, Andrew Aston, BS3, Ohemaa Kwakyi, BS3, Hunter Risher, BS2, Esther Ogboukiri, BS3 and Ellen M Mowry, MD, MCR4, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neurology, Johns Hopkins University, Baltimore, MD, (3)Neurology, Johns Hopkins Hospital, Baltimore, MD, (4)Neurology, Johns Hopkins School of Medicine, Baltimore, MD |
| 2018 | NB05 | Poster | Non-imaging Biomarkers |
Biosensor Detection of Upper Limb Dysfunction in Multiple Sclerosis |
Leena Suleiman, BA1, Andrew Yousef, BS1, Soren Jonzzon, BS, MS1, Jennifer Arjona, BA, MS2, Alireza Akhbardeh, BS, MS, PhD3, Bardia Nourbakhsh, MAS, MD1, Pierre-Antoine Gourraud, PhD, MPH1 and Jennifer Graves, MD, PhD, MAS1, (1)Neurology, UCSF, San Francisco, CA, (2)UCSF Neurology, MS Research Coordinators, San Francisco, CA, (3)Stanford University, Palo Alto, CA |
| 2018 | NB06 | Poster | Non-imaging Biomarkers |
Impact of Ocrelizumab Treatment on PML Risk Biomarkers |
Eric Williamson, MD and Jakob Dobrowolski, BS, Neurology, University of Pennsylvania, Philadelphia, PA |
| 2018 | NB07 | Poster | Non-imaging Biomarkers |
The Ratio of 1st and 2nd Metatarsal Head Plantar Loading in Individuals with MS and Controls |
Cheryl Fields, BS/DO Candidate 20181, Anna Srouji, BS, MS1, Allen Tsai, BS2, Kennedy Abbott, BA1, Michael A Ciaramella, BA3, Rock Positano, DPM, MPH4, Howard J Hillstrom, PhD5 and Mary Ann Picone, MD1, (1)Holy Name Medical Center, Teaneck, NJ, (2)HSS, New York, NY, (3)Non-Surgical Foot and Ankle Service, Hospital for Special Surgery, New York, NY, (4)Hospital for Special Surgery, Rehabilitation-LRMALab, New York, NY, (5)Rehabilitation – LRMALab, Hospital for Special Surgery, New York, NY |
| 2018 | NB08 | Poster | Non-imaging Biomarkers |
Relationship Between Skin Tone and Pediatric-Onset Multiple Sclerosis (MS) |
Candice L Dunn, BSc1, Carmen Yea, MSc2, Heather E Hanwell, PhD3, E. Ann Yeh, MD, MA, FRCPC, Dip ABPN4, Ruth Ann Marrie, MD, PhD, FRCPC5, Amit Bar-Or, MD6, Neda Ebrahimi, PhD2, Brenda Banwell, MD1 and Julia O’Mahony, BSc7, (1)Children’s Hospital of Philadelphia, Philadelphia, PA, (2)The Hospital for Sick Children, Toronto, ON, Canada, (3)Neurosciences and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, (4)Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (5)Department of Medicine, University of Manitoba, Winnipeg, MB, Canada, (6)University of Pennsylvania, Philadelphia, PA, (7)Hospital for Sick Children, Toronto, ON, Canada |
| 2018 | NB09 | Poster | Non-imaging Biomarkers |
Metabolomic Changes Associated with a Time-Restricted Diet in People with Multiple Sclerosis |
Samantha N Roman, B.S.1, Kathryn C Fitzgerald, Sc.M., Sc.D.1 and Ellen M Mowry, MD, MCR2, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neurology, Johns Hopkins School of Medicine, Baltimore, MD |
| 2018 | NB10 | Poster | Non-imaging Biomarkers |
Metabolomic Changes Associated with Calorie Restriction in People with Multiple Sclerosis |
Samantha N Roman, B.S.1, Kathryn C Fitzgerald, Sc.M., Sc.D.1 and Ellen M Mowry, MD, MCR2, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neurology, Johns Hopkins School of Medicine, Baltimore, MD |